Header cover image

Australian Biotech Breakthroughs

Results

2

0 new
Biotech stocks worldwide which are expected to become profitable in the next 3 years.

2 companies

Aroa Biosurgery

Market Cap: AU$151.8m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

ARX

AU$0.41

7D

-5.7%

1Y

-27.2%

PYC Therapeutics

Market Cap: AU$633.6m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

PYC

AU$1.09

7D

-12.8%

1Y

17.2%

Page 1 of 1